News Updates from the 83rd Scientific Sessions
Rodica Busui, MD, PhD, American Diabetes Association® President of Medicine & Science, recalled her earliest days of working in a clinic in Romania, her fellowship at the University of Michigan, and choosing diabetes as her life’s work. She also discussed the new clinical research program in diabetes she was asked to develop.
Read more
Alka M. Kanaya, MD, shared clinical implications from her research, Mediators of Atherosclerosis in South Asians Living in America, which aims to understand the factors that lead to diabetes in South Asian populations. South Asian individuals in the U.S. have the highest prevalence of diabetes compared to other racial or ethnic groups. Read more
The work of physician-scientist Matthias H. Tschöp, MD, has transformed the fight against obesity and diabetes. As the Banting Medal for Scientific Achievement honoree, he shared insights into the ongoing quest to reverse obesity, including the possibilities offered by the approval of tirzepatide for the treatment of type 2 diabetes. Read more
Studies harness real-world data for vital insights into patient populations and can help determine the delivery of care for patients with diabetes. Experts, including Kristi Reynolds, PhD, MPH, FAHA, FACE, discussed the utility of real-world data and how having access to electronic health records can help in examining long-term trends. Read more
Guidelines and standards of care are helpful for many, but some populations require a more individualized approach to diabetes care. Experts, including Rodolfo J. Galindo, MD, shared the tools they’ve made available to patients who may need alternative ways to monitor and self-manage their diabetes. Read more
Data continue to provide strong evidence favoring metabolic surgery to other treatment options for type 2 diabetes remission. Principal Investigator John Kirwan, MSc, PhD, will present ARMMS-T2D study results comparing surgery versus medical and lifestyle intervention in patients with the disease, as well as long-term effects post-surgery. Read more
Experts in diabetes and eye health will discuss how the therapies used in the treatment of diabetes relate to the development and progression of diabetic retinopathy. Risa Wolf, MD, will share data that suggests GLP-1 receptor agonists can worsen diabetic retinopathy. Read more
The COORDINATE-Diabetes trial studied the effects of prescribing three recommended classes of drugs to patients with both type 2 diabetes and atherosclerotic disease compared to standard care. Investigators including Neha Pagidipati, MD, MPH, will review the results in a Scientific Sessions symposium.
Read more
Phase 2 trial results suggest retatrutide may offer a triple therapy option to address the multiple metabolic factors that affect people who are obese, regardless of type 2 diabetes status, said Arun J. Sanyal, MD. He and other investigators will share new data on this GIP/GLP-1/glucagon receptor triagonist and its effects on obesity, type 2 diabetes, and nonalcoholic steatohepatitis.
Read more
Sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists are making an impact in treating patients with type 2 diabetes who may be at high risk for atherosclerotic cardiovascular disease and heart failure. Darren K. McGuire, MD, MHSc, will review both classes of drugs as part of an expert panel. Read more
As treatments for diabetic kidney disease evolve, a panel of diabetes care experts will discuss what is happening in the world of antihyperglycemic and antihypertensive agents—and beyond—as the disease continues to be a prevalent complication from diabetes. Christine Limonte, MD, will discuss whether diabetes care professionals are following guidelines in using new therapies. Read more
Michael Sefton, ScD, and a collaborative panel of experts will discuss cell therapy and strategies for delivering it to patients with type 1 diabetes. Topics will include identifying sites for the therapy, protecting the immune cells, and, once the cells are transplanted, monitoring the patient. Read more
Burnout has already contributed to a reduction in the workforce dedicated to caring for patients living with diabetes. Marie Brown, MD, of the American Medical Association will explain how to effectively address clinical burnout at an organizational level using real-world examples of success centered on practice efficiency. Read more
A panel of nephrology and diabetes experts, including Titilayo O. Ilori, MD, MSc, will discuss the impact of race, ethnicity, and underrepresentation of vulnerable populations in clinical trials in relation to diabetes and kidney disease. Read more
Scientific Sessions attendees in San Diego are invited to converse with Mandeep Bajaj, MBBS, editor of ADA’s partner journal BMJ Open, Diabetes Research & Care, and ADA’s President-elect of Medicine & Science; David A. D’Alessio, MD, editor of Diabetes; and Steve E. Kahn, MB, ChB, editor of Diabetes Care. Read more
In a symposium beginning Sunday at 4:30 p.m. in Ballroom 20A-C, Vanita R. Aroda, MD, will share results from two trials, OASIS 1 and PIONEER PLUS, and discuss the effectiveness of higher dose semaglutide in treating patients with type 2 diabetes as well as patients with obesity without type 2 diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Raghu G. Mirmira, MD, PhD, is the recipient of the 2023 Albert Renold Award. The award honors an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the development of communities of scientists to enhance diabetes research. Dr. Mirmira will be recognized during the National Scientific & Health Care Achievement Awards Presentation on Monday at 9:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Presenter Revital Nimri, MD, shares insight into a panel discussion that begins Sunday at 4:30 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Filip K. Knop, MD, PhD, shares insight into a symposium that begins Sunday at 4:30 p.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
During a debate beginning Sunday at 3:15 p.m. PT in Room 30, Jennifer Raymond, MD, MCR, will make the case for using telehealth in psychological care, while Michael A. Harris, PhD, will make the case for more research into telehealth models before wide adoption for this kind of care. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Silva Arslanian, MD, is the recipient of the 2023 Outstanding Achievement in Clinical Diabetes Research Award. The award honors exceptional contributions in patient-oriented clinical outcomes research that have had a significant impact on diabetes prevention and treatment. Dr. Arslanian will be recognized during the National Scientific & Health Care Achievement Awards Presentation on Monday at 9:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
In a debate beginning Sunday at 3:15 p.m. PT in Ballroom 6A-B, James L. Kirkland, MD, PhD, will discuss the use of senolytic drugs, and Anil Bhushan, PhD, will share his immunotherapy approach to eliminate senescent cells. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Michael A. Harris, PhD, shares insight into a debate that begins Sunday at 3:15 p.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Mandeep Bajaj, MBBS, FRCP, is the recipient of the 2023 Outstanding Physician Clinician in Diabetes Award. The award rewards and honors meritorious contributions to diabetes clinical practice. Dr. Bajaj will be recognized during the National Scientific & Health Care Achievement Awards Presentation on Monday at 9:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Helen R. Murphy, MBBChBAO, MD, FRACP, is the recipient of the 2023 Norbert Freinkel Award. The award honors outstanding scientific achievement in the understanding and treatment of diabetes and pregnancy. Dr. Murphy will deliver the Norbert Freinkel Award Lecture on Sunday at 1:30 p.m. in Room 28. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Save big on official American Diabetes Association® apparel, gifts, and professional books at the Shop Diabetes Store in the Sails Pavilion in the upper level of the convention center. Every purchase supports diabetes research, advocacy, and educational programs. Hours of operation are Sunday from 7:30 a.m. to 6:30 p.m. PT and on Monday from 7:30 a.m. to 4:30 p.m. PT.
Amy Valent, DO, MCR, and Teri Hernandez, PhD, RN, debate whether pregnant persons with gestational diabetes should follow a reduced-carbohydrate meal plan. The subject was the focus of a full debate session on Saturday at the Scientific Sessions, and registered attendees can now view that recording and others on the virtual meeting platform at ADA2023.org.
Presenter Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, APh, shares insight into a professional group discussion that begins Sunday at 11:30 a.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Kevin Miller, DO, shares insight into a professional group discussion that begins Sunday at 11:30 a.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read MoreLisa Staimez, PhD, MPH, and Sridharan Raghavan, MD, PhD, debate population health approaches versus personalized medicine approaches in type 2 diabetes prevention. The subject was the focus of a full debate session on Friday at the Scientific Sessions, and registered attendees can now view that recording on the virtual meeting platform at ADA2023.org.
Visit the Exhibit Hall on the ground level of the convention center to see the latest products and services in diabetes care, as well as featured industry events. The hall is open from 10:00 a.m. to 4:00 p.m. PT on Sunday and 10:00 a.m. to 2:00 p.m. PT on Monday.
ADA President, Medicine & Science Rodica Busui, MD, PhD, will address the 83rd Scientific Sessions during a special session Sunday at 9:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Matthias H. Tschöp, MD, is the recipient of the 2023 Banting Medal for Scientific Achievement. The award recognizes significant, long-term contributions to the understanding, treatment, or prevention of diabetes. Dr. Tschöp will deliver the Banting Medal for Scientific Achievement Lecture on Sunday at 10:30 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
ADA National Health Disparities Committee Chair Ashby F. Walker, PhD, discusses the impactful abstracts on health disparities and health equity that the committee selected as part of the 83rd Scientific Sessions. The Poster Hall is open Sunday from 7:30 a.m. to 6:30 p.m. PT and Monday from 7:30 a.m. to 2:00 p.m. PT.
Presenter Kenneth Cusi, MD, FACP, FACE, shares insight into a symposium that begins Sunday at 8:00 a.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
This symposium includes presentations on food as medicine, how to talk diabetes nutrition in five minutes or less, and binge-eating disorder and weight stigma. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
This symposium includes presentations on the contribution of gastric inhibitory peptide and glucagon in dual and triple agonism, the role for amylin in monotherapy and combination therapy, the contribution of PYY in combination treatment with GLP-1, and clinical implications of nutrient-stimulated hormone pharmacotherapy. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
During a symposium beginning Sunday at 8:00 a.m. PT in Ballroom 20A-C, experts including Eric L. Johnson, MD, will take a closer look at changes to the American Diabetes Association® Standards of Care in Diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
In a symposium beginning Sunday at 8:00 a.m. PT in Room 28, diabetes and cardiovascular experts, including Jan Borén, MD, PhD, will discuss cardiovascular disease and people with diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read MoreScientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews noteworthy sessions on Sunday's schedule.
During a special Saturday morning lecture, American Diabetes Association® President of Health Care & Education Janet Brown-Friday, RN, MSN, MPH, urged the medical community to be inclusive of sex and gender, race and ethnicity among staff and participants when recruiting for trials. This also includes helping make access to trials more available to participants.
Read more
A. Enrique Caballero, MD, advocates for thoughtfully designed diabetes education and prevention programs tailored to “speak to” the different audiences for which they are intended in order to optimize diabetes care and achieve better outcomes. He is the recipient of this year’s Outstanding Educator in Diabetes Award. Read more
Various self-assessment tools exist to help patients with diabetes monitor their daily activities and provide their care teams with insights into glucose levels. Methods for tracking behavioral markers include sleep monitoring and actigraphy devices to track physical activity. Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN, discussed ecological momentary assessments. Read more
Dietary choices are crucial for managing type 2 diabetes. Experts including Roy Taylor, MD, shared their perspectives on nutrition programs that have helped patients reduce or manage type 2 diabetes while also living healthier lives. These programs incorporate low-calorie diets, low-carb diets, and glycemic excursion minimization. Read more
Vanita R. Aroda, MD, will share results from two trials, OASIS 1 and PIONEER PLUS, and discuss the effectiveness of higher dose semaglutide in treating patients with type 2 diabetes as well as patients with obesity without type 2 diabetes. She will discuss how a high-dose semaglutide regimen can help patients reach their health goals. Read more
Forty years after the launch of the Diabetes Control and Complications Trial, the Epidemiology of Diabetes Interventions and Complications study continues to observe and report on 1,000 patients. Gayle Lorenzi, RN, CDCES, who manages the San Diego DCCT/EDIC site, and other investigators will discuss how the data gleaned from this sustained research has transformed management of type 1 diabetes.
Read more
Raphael Scharfmann, PhD, will provide insight on the earliest beta cells: fetal pancreatic beta cells. His focus will be on the human fetal pancreas and what it can reveal about beta-cell identity. Other panelists will discuss postnatal beta cells and beta-cell aging. Read more